LACHENAIE, QC, Aug. 26 /CNW Telbec/ - Capital Pro-Égaux Inc.
(the "Company") reports that it's wholly owned subsidiary Technique
d'usinage Sinlab Inc., has received translated court actions from Nobel
Biocare to attempt to nullify the company German and Italian
superstructure patent1,043,960 issued September 3rd of 2003.
These procedures are filed by Nobel Biocare subsequently to a COURT
ACTION filed on June 25th, 2010 by Technique
d'usinage Sinlab Inc against BioCad Medical Inc, a Québec city based
company wholly owned by Nobel Biocare, for patent infringement of the
Company Canadian patent 2,575,964 issued on 27th of May 2008.
About Pro-Égaux Inc.
Pro-Égaux through its wholly owned subsidiary, Technique d'usinage
Sinlab Inc., is a company based in Lachenaie, Quebec, specializing
mainly in the conception and design of titanium products to be used in
the dental prosthesis restoration industry.
"Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release."
SOURCE Capital Pro-Égaux Inc.
For further information: For further information:
|Capital Pro-Égaux Inc.|
Tel.: (514) 616-0612
Fax: (450) 226-1923